中药雾化吸入治疗慢性阻塞性肺疾病的临床效果及推广价值分析  

Treating chronic obstructive pulmonary disease by TCM nebulization

作　　者：陈君容 Chen Junrong

机构地区：[1]东莞市南城医院,广东东莞523071

出　　处：《中医临床研究》2019年第5期28-29,共2页Clinical Journal Of Chinese Medicine

摘　　要：目的:探讨慢性阻塞性肺疾病患者应用中药雾化吸入治疗的临床效果。方法:将2016年5月-2018年4月在我院接受治疗的82例慢性阻塞性肺疾病患者选为研究目标,依照随机法分为两组,即对照组与试验组,各41例。对照组患者给予常规西药治疗,试验组患者在对照组基础上给予中药雾化吸入治疗,对两组患者临床疗效及肺功能进行统计比较。结果:试验组治疗总有效率高于对照组,数据分别为95.1%、80.5%,差异有统计学意义(P <0.05)。试验组1 s用力呼气容积(FEV_1)、最大呼气流量(PEF)、FEV_1/用力肺活量(FVC)均大于对照组,差异有统计学意义(P <0.05)。结论:慢性阻塞性肺疾病患者应用中药雾化吸入治疗的临床效果更加确切,能够有效减轻患者临床症状,改善患者肺功能,值得临床进一步应用与借鉴。Objective: To investigate clinical efficacy of TCM nebulization on chronic obstructive pulmonary disease. Methods: May 2016-April 2018, 82 cases were divided into 2 groups, 41 cases in each. The control group was given conventional treatment;and the experimental group was given TCM nebulization more. Results: The total efficiency was 95.1% in the experimental group, higher than 80.5% in the control group, P <0.05. The FEV 1 , PEF and FEV 1 /FVC in the experimental group were greater than those in the control group ( P <0.05). Conclusion: TCM nebulization on chronic obstructive pulmonary disease, can effectively alleviate the clinical symptoms of patients and improve their lung function, and is worthy of promotion.

关 键 词：慢性阻塞性肺疾病 中药雾化吸入 临床疗效 肺功能 

分 类 号：R563.1[医药卫生—呼吸系统]